Biodegradable intraoperative system for bone infection treatment. I. The drug/polymer interaction

International Journal of Pharmaceutics

Volumn 143, Issue 2, 1996, Pages 195-201

  Lannuccelli, V ^a   Coppi, G ^a   Cameroni, R ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

alginate; calcium; gentamicin sulphate; implant; interaction; viscosity

Indexed keywords

ALGINIC ACID; GENTAMICIN; POLYMER;

ARTICLE; BIODEGRADATION; BONE INFECTION; DRUG FORMULATION; DRUG RELEASE; IMPLANT; IN VITRO STUDY; PRIORITY JOURNAL; VISCOSITY;

EID: 0030575738     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(96)04703-5     Document Type: Article

References (19)

1. Bystricky, S., Malovikova, A. and Sticzay, T., Interaction of alginates and pectins with cationic polypeptides. Carbonhydr. Polym., 13 (1990) 283-294.
2. Firsov, A.A., Nazarov, A.D. and Fomina, I.P., Biodegradable implants containing gentamicin: drug release and pharmacokinetics. Drug Dev. Ind. Pharm., 13 (1987) 1651-1674.
3. Fuoss, R.M., Viscosity function for polyelectrolytes. J. Polym. Sci., 3 (1948) 603-604.
4. Gordon, C.A., Hodges, N.A. and Marriott, C., Antibiotic interaction and diffusion through alginate and exopolysaccharide of cystic fibrosis-derived Pseudomonas aeruginosa. J. Antimicrob. Chemother., 22 (1988) 667-674.
5. Grant, G.T., Morris, E.R., Rees, D.A., Smith, P.J.C. and Thom, D., Biological interactions between polysaccharides and divalent cations: the egg-box model. Febs Letts., 32 (1973) 195-198.
6. Handbook of Pharmaceutical Excipients. American Pharmaceutical Association, Washington, and the Pharmaceutical Society of Great Britain, London, 1986, pp. 5.
7. Kronenthal, R.L., Biodegradable polymers in medicine and surgery. In Kronenthal, R.L., Oser, Z. and Martin, E. (Eds.), Polymers in Medicine and Surgery, Plenum Press, New York, 1975, pp. 119-133.
8. Kwok, K.K., Groves, M.J. and Burgess, D.J., Production of 5-15 μm diameter alginate-polylysine microcapsules by an air-atomization technique. Pharm. Res., 8 (1991) 341-344.
9. McDowell, RH., Properties of Alginates, Alginate Industries, London, 1986, pp. 41-48.
10. Morris, E.R., Rees, D.A., Thom, D. and Boyd, J., Chiroptical and stoichiometric evidence of a specific, primary dimerization process in alginate gelation. Carbohydr. Res., 66 (1978) 145-154.
11. Penman, A. and Sanderson, G.R., Method for the determination of uronic acid sequence in alginate. Carbohydr. Res., 25 (1972) 273-282.
12. Rajaonarivony, M., Vauthier, C., Couarraze, G., Puisieux, F. and Couvreur, P., Development of a new drug carrier made from alginate. J. Pharm. Sci., 82 (1993) 912-917.
13. Rees, D.A., Structure, conformation and mechanism in the formation of polysaccharide gels and networks. Advan. Carbohydr. Chem. Biochem., 24 (1969) 267-332.
14. Sampath, S.S. and Robinson, D.H., Comparison of new and existing spectrophotometric methods for the analysis of tobramycin and other aminoglycosides. J. Pharm. Sci., 79 (1990) 428-431.
15. Segi, N., Yotsuyanagi, T. and Ikeda, K., Interaction of calcium-induced alginate gel beads with propranolol. Chem. Pharm. Bull., 37 (1989) 3092-3095.
16. Stockwell, A.F., Davis, S.S. and Walker, S.E., In vitro evaluation of alginate gel systems as sustained release drug delivery systems. J. Controlled Release, 3 (1986) 167-175.
17. Sun, A.M. and O'Shea, G.M., Microencapsulation of living cells - a long-term delivery system. J. Controlled Release, 2 (1985) 137-141.
18. Tanaka, H., Matsumura, M. and Veliky, I.A., Diffusion characteristics of substrates in Ca-alginate gel beads. Biotechnol. Bioeng., 26 (1984) 53-58.
19. Wan, L.S.C., Heng, P.W.S. and Chan, L.W., Drug encapsulation in alginate microspheres by emulsification. J. Microencapsulation, 9 (1992) 309-316.